Purple Biotech (PPBT)
(Real Time Quote from BATS)
$0.57 USD
+0.01 (1.23%)
Updated May 21, 2024 02:34 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | -0.15 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -88.24% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.46 |
Next Year | -0.46 |
EPS (TTM) | -0.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.15 | -0.13 | -0.46 | -0.46 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.15 | -0.13 | -0.46 | -0.46 |
High Estimate | -0.15 | -0.13 | -0.46 | -0.46 |
Low Estimate | -0.15 | -0.13 | -0.46 | -0.46 |
Year ago EPS | -0.21 | -0.23 | -1.00 | -0.46 |
Year over Year Growth Est. | 28.57% | 43.48% | 54.00% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.15 | -0.13 | -0.46 | -0.46 |
7 Days Ago | -0.15 | -0.13 | -0.46 | -0.46 |
30 Days Ago | -0.15 | -0.13 | -0.46 | -0.46 |
60 Days Ago | -0.15 | -0.13 | -0.46 | -0.46 |
90 Days Ago | NA | NA | -0.56 | -0.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.13 | -0.46 | -0.46 |
Zacks Consensus Estimate | -0.15 | -0.13 | -0.46 | -0.46 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.21 | -0.23 | -0.21 | NA |
Estimate | -0.17 | -0.22 | -0.25 | -0.35 | NA |
Difference | -0.15 | 0.01 | 0.02 | 0.14 | 0.01 |
Surprise | -88.24% | 4.55% | 8.00% | 40.00% | -8.92% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more